HOME > Business Wire > Article
Kolmar BNH Sharpens Global Competitiveness with Dual Functionality of HemoHIM
SEOUL, South Korea--( BUSINESS WIRE )-- Kolmar BNH (KOSDAQ: 200130), a leading Original Development Manufacturing (ODM) company for health functional foods, strengthens its market position by acquiring certification for the additional functionality of HemoHIM, a renowned Korean health supplement.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240620376394/en/
![HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy, contains Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora. It was launched in Taiwan last month. (Photo: Kolmar BNH)](https://mms.businesswire.com/media/20240620376394/en/2166085/4/HemoHIM_G.jpg)
HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy, contains Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora. It was launched in Taiwan last month. (Photo: Kolmar BNH)
The company secured approval from the Ministry of Food and Drug Safety for the fatigue-improving function of the HemoHIM extract complex of angelica gigas, etc., derived from angelica gigas and other components in 2023. This achievement was made six years after the launch of its HemoHIM Sustainable Technology Development Project. As a result, HemoHIM came to the market as a dual-functional health product designed to boost immune function and reduce fatigue.
HemoHIM, developed by Kolmar BNH in 2006, is the nation’s first individually-approved immune-boosting health supplement, formulated using indigenous natural ingredients like angelica gigas, cnidium officinale, and paeonia japonica. Distributed by Atomy, it's now a global success, exported to over 20 countries and generating over KRW 2 trillion in sales with exports exceeding $200 million. It has remained Korea's top-selling immune booster for over a decade.
Kolmar BNH validated the fatigue improvement function of HemoHIM through extensive clinical (human trials) and non-clinical trials (cell tests). In trials involving adults aged 30 to 59 experiencing fatigue, significant enhancements were observed in fatigue measures, including the Fatigue Severity Scale (FSS) and Multidimensional Fatigue Inventory (MFI), following consumption of the HemoHIM extract complex of angelica gigas, etc. These findings were published in Phytomedicine Plus, an international journal dedicated to natural medicine, with patents registered in Korea and Russia.
Continuing its commitment to innovation following the launch of HemoHIM, Kolmar BNH allocates over 2% of its annual sales to R&D. This investment aims to enhance product functionality and fortify competitive advantage.
HemoHIM G, targeting the global market, is one of the results of such dedication to R&D. Launched in Taiwan last month, HemoHIM G is a new product for export that has made meticulous adjustments to its raw materials and ingredient proportions to comply with international food regulations. Its key ingredients such as Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora went through rigorous sourcing procedures and stringent quality control. The taste and aroma profiles were tailored to suit the preferences of global consumers. Furthermore, its safety has been certified in the prestigious academic journal “Toxicological Research”, accredited at the SCIE level.
Kolmar BNH official said, "Through relentless research and development efforts, Kolmar BNH has enhanced the competitiveness of HemoHIM. We are dedicated to promoting K-health functional food globally through ongoing innovations in HemoHIM."
View source version on businesswire.com: https://www.businesswire.com/news/home/20240620376394/en/
Source: Kolmar BNH
Business Wire
-
06/28 22:00 Effortlessly Maintain a Pristine Lawn with the Yard Force Cable Plug G...
-
06/28 02:10 Mitsubishi Electric Delivers Smart-meter System to Taiwan Market as Fi...
-
06/28 01:58 ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, ...
-
06/27 23:30 Oasis Announces Campaign to Improve Ain Corporate Governance (Stock Co...
-
06/27 22:00 Revieve and MatsukiyoCocokara Introduce Groundbreaking Beauty Solution...
-
06/27 15:30 Audiostock Collaborates with Adobe to Launch Music Provision via Audio...
-
06/27 12:00 ispace RESILIENCE Lunar Lander Successfully Achieves Testing Milestone...
-
06/27 08:00 Faraday Joins Intel Foundry Accelerator Design Services Alliance to Ta...
-
06/27 07:40 Palliser Capital Notes the Voting Result at Keisei Electric Railway AGM
-
06/27 01:00 Seven Toshiba Gas Insulated Transformers Enter Operation in Makkah
-
06/26 23:00 Enhance Your Garden Maintenance with the Yard Force LSC18-JP at Yard F...
-
06/26 07:05 Takeda Announces New Assignments of Directors
-
06/26 00:00 UL Solutions Helps Grand Hyatt Seoul Advance Guest and Employee Health...
-
06/25 12:00 Dermavant Announces Approval of Tapinarof in both Psoriasis and Atopic...
-
06/25 10:00 4iG Subsidiaries Consolidate All Retail Customers on Netcracker’s Di...
-
06/25 01:00 DNP Achieved Over 85% Repulpability for High Barrier Paper Mono-Materi...
-
06/24 20:32 Music Industry Unites to Protect the Rights of Musicians amid the Grow...
-
06/24 10:03 MUFG Bank, Ltd. announces Regarding Administrative Action by the Finan...
-
06/23 02:30 Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab,...
-
06/21 20:00 Takeda Receives Approval from European Commission for FRUZAQLA in Prev...
-
06/21 07:15 Melodia Therapeutics and Alivexis Sign Exclusive License Agreement for...
-
06/21 06:00 Kolmar BNH Sharpens Global Competitiveness with Dual Functionality of ...
-
06/21 05:52 Independent Proxy Advisors ISS & Glass Lewis Back Oasis Proposals ...
-
06/21 02:10 Mitsubishi Electric Data Scientist Team Wins Gold in Kaggle Competition
-
06/20 13:51 teamLab Borderless Jeddah | The Record-Breaking Digital Art Museum Ope...
-
06/20 12:30 Renesas Completes Acquisition of Transphorm
-
06/20 12:00 Renesas’ R-Car Open Access Platform Accelerates Software-Defined Veh...
-
06/20 04:00 Northern Trust Asset Management Announces Naoto Komoro as Head of Japa...
-
06/20 02:00 Toyoda Gosei Invests in Synspective Inc., a Startup That Develops and ...
-
06/19 18:00